References
- Turgay Yildirim Ö, Akşit E, Aydin F, et al. Efficacy of direct oral anticoagulants on left ventricular thrombus. J Thromb Thrombolysis. 2019;44:1.
- Fleddermann AM, Hayes CH, Magalski A, Main ML. Efficacy of direct acting oral anticoagulants in treatment of left ventricular thrombus. Am J Cardiol. 2019;124:367–372.
- Tomasoni D, Sciatti E, Bonelli A, et al. Direct oral anticoagulants for the treatment of left ventricular thrombus – a new indication? A meta-summary of case reports. J Cardiovasc Pharmacol. 2020;75:530–534.
- Sedhom R, Abdelmaseeh P, Megaly M, et al. Use of direct oral anticoagulants in the treatment of left ventricular thrombi: a systematic review. Am J Med. 2020;590:584–590.
- Yassin AS, Abubakar H, Mishra T, et al. Rivaroxaban for left ventricular thrombus. Am J Ther. 2019;26:e511–e515.
- Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008;143:180–190.
- Brotman DJ, Deitcher SR, Lip GY, et al. Virchow's triad revisited. South Med J. 2004;97(2):213–214.
- Y-Hassan S, Holmin S, Abdula G, et al. Thrombo-embolic complications in takotsubo syndrome: review and demonstration of an illustrative case. Clin Cardiol. 2019;42:312–319.
- Habash F, Vallurupalli S. Challenges in management of left ventricular thrombus. Ther Adv Cardiovasc Dis. 2017;11:203–213.
- Elikowski W, Małek-Elikowska M, Wróblewski D, et al. Apixaban in left ventricular thrombi treatment – a report of seven cases. Pol Merkur Lekarski. 2018;44:276–279.
- Smetana KS, Dunne J, Parrott K, et al. Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series. J Thromb Thrombolysis. 2017;44:519–524.
- Jones DA, Wright P, Alizadeh MA, et al. The use of novel oral anti-coagulant’s (NOAC) compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction (AMI). Eur Hear J Cardiovasc Pharmacother. 2020.
- Leow AST, Sia CH, Tan BYQ, et al. A meta-summary of case reports of non-vitamin K antagonist oral anticoagulant use in patients with left ventricular thrombus. J Thromb Thrombolysis. 2018;46:68–73.
- Guyatt GH, Akl EA, Crowther M, et al., American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:7S–47S.
- Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955–962.
- Manesh RP, Kenneth WM, Jyotsna G, et al., for the ROCKET AF Investigators*. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–891.
- Christopher BG, John HA, John JVM, et al., for the ARISTOTLE Committees and Investigators*. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–992.
- Keren A, Goldberg S, Gottlieb S, et al. Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol. 1990;15:790–800.
- Asinger RW, Mikell FL, Elsperger J, et al. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction: serial evaluation by two-dimensional echocardiography. N Engl J Med. 1981;305:297–302.
- Jugdutt BI, Sivaram CA, Wortman C, et al. Prospective two-dimensional echocardiographic evaluation of left ventricular thrombus and embolism after acute myocardial infarction. J Am Coll Cardiol. 1989;13:554–564.
- Cochran JM, Jia X, Kaczmarek J, et al. Direct oral anticoagulants in the treatment of left ventricular thrombus: a retrospective, multicenter study and meta-analysis of existing data. J Cardiovasc Pharmacol Ther. 2021;26:173–178.